Stent

CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System

Advanced Platinum Surface Maximizes Biocompatibility and Biostabilityin a Bare-Metal Stent BURLINGTON, Mass., June 23 /PRNewswire/ -- CorNova Inc. today announced that it has received CE mark approval for its Valecor Platinum Coronary Stent System. (Logo: http://www.newscom.com/...

Newest Coated Stent Does Well in Real-World Trial

Safe and effective in an 'all-comer population,' researchers say WEDNESDAY, June 17 (HealthDay News) -- The newest drug-coated stent has performed well in a real-life trial, Dutch cardiologists report. The Xience stent -- a flexible metal-mesh tube coated with the drug everolimus --...

Broncus Technologies' Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group

WALTHAM, Mass., June 16 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rise in the US prevalence of emphysema is prompting device firms to develop endoscopic devices used to diagnose or treat the condition. Curre...

XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration

MENLO PARK, Calif., June 4 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that the Company received conditional approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) authorizing it to begin its pivotal clinical pro...

Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study

Safety and Efficacy Rates in Patients with Challenging Anatomy Consistent with Superior Results from Randomized Clinical Trials BARCELONA, Spain, May 21 /PRNewswire-FirstCall/ -- New data presented today at EuroPCR from an international, post-approval, single-arm study show that Abbott's mark...

SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System

NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced positive outcomes from a substudy of patients with left main coronary disease who were treated with the TAXUS(R) Express2(R) Paclitaxel-Eluting Coronary Stent System. ...

Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease

MOBILITY trial showcases company's leadership in developing innovative endovascular treatment options ABBOTT PARK, Ill., April 1 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro(T...

XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System

60 millimeter Custom NX 60 is the world's longest coronary stent to ever be approved MENLO PARK, Calif., March 19 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced that it has received CE Mark approval for its CUSTOM NX drug-eluting stent (DES) System. The CE Mark indic...

Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System

Japanese patients now have access to second-generation drug-eluting stent NATICK, Mass., March 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the launch of its TAXUS(R) Liberte(R) Paclitaxel-Eluting Coronary Stent System in Japan. The product was app...

Blood Flow Measurement Boosts Stent Outcomes

Technology reduces deaths, complications, but may be too costly for some centers, experts say WEDNESDAY, Jan. 14 (HealthDay News) -- A sophisticated measure of blood flow to determine where artery-opening stents should be implanted is more effective than the X-ray examinations now comm...

More>>

Stent in Medical Technology

Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System

ANN ARBOR, Mich., July 24 /PRNewswire/ -- Terumo Cardiovascular Systems (Terumo CVS) announced that it has initiated a Phase II Clinical Trial for the Anaconda(TM) AAA (Abdominal Aortic Aneurysm) Stent Graft System in the U.S. The Anaconda system is manufactured by Scotland-based Terumo subs...

Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013

Positive clinical data, competitor focus, and new drug-eluting technologies to drive lower extremity procedures in Europe , according to Millennium Research Group WALTHAM, Mass., May 28 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Peripheral Vasc...

Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease

NATICK, Mass., May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC(TM) Self-Expanding Nitinol Stent System for the treatment of iliac artery disea...

SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(R) Stent System More Cost Effective Than Bypass Surgery in Patients With Complex Coronary Artery Disease

NATICK, Mass. and BARCELONA, Spain, May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial. The results found that percutaneous coronary ...

Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms

NATICK, Mass. and ORLANDO, Fla., March 29 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of two-year data from the SPIRIT II and III Trials. SPIRIT II and SPIRIT III are pros...

AHRQ-Funded Study Finds Lower Risk of Death and Heart Attack in Patients With Drug-Coated Stent Implants Compared to Those With Bare Metal Stents

ROCKVILLE, Md., March 28 /PRNewswire-USNewswire/ -- Heart disease patients 65 and older who receive stents coated with medicine to prevent blockages are more likely to survive and less likely to suffer a heart attack than people fitted with stents not coated with medication, according to a new stu...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

ABBOTT PARK, Ill., March 24 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) today announced the initiation of the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company's fully bioabsorbable drug eluting coronary stent. This second phase of the ABSORB clinic...

Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use

Nearly 150,000 PCIs Were Performed on AMI Patients in 2008, According to Millennium Research Group WALTHAM, Mass., Feb. 18 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Interventional Cardiology Devices 2009 report, the use of drug-eluting stents will conti...

MGuard(TM) Coronary Stent System Approved in Israel

TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced that the MGuard(TM) coronary stent system has been approved for use in Israel by the Israeli Ministry of Health. The MGuard(TM) stent system presents a novel combination of a coronary stent merged with an embolic protec...

Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years

New Analysis of SPIRIT II and SPIRIT III Data Confirms Patients Treated with XIENCE V Are at Lower Risk of Experiencing Death, a Heart Attack or a Repeat Procedure Compared to TAXUS(R) at Two Years WASHINGTON, Oct. 13 /PRNewswire-FirstCall/ -- Data from an independent meta-analysis ...

More>>

Stent in Medical Products

PROTEGE RX Carotid Stent System

Description: Proprietary EX.P.R.T. Release Technology essentially eliminates premature deployment or jumping No stent shortening Unique anatomically designed tapered stent for better fit in the carotid bifurcation 0.014 Rapid Exchange catheter with 6 Fr low crossing profile and flex...
Company:ev3, Inc.

LifeStent FlexStar Stent Delivery Systems

Description: LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
Company:Edwards Lifesciences Corporation

RX ACCULINK Carotid Stent System

Description: The RX ACCULINK Carotid Stent System is designed to provide easy and accurate stent placement in patients who have carotid atherosclerosis and are at high risk for conventional surgery. The 0.014 guide wire compatible RX ACCULINK Carotid Stent System is 6F sheath/8F guide catheter compatible for a...
Company:Abbott Vascular

Siemens Video: 3D Stent Surgery

Description: ...
Company:Siemens Medical Solutions USA, Inc.

CoStar Paclitaxel-eluting Coronary Stent System

Description: BIOTRONIK AG will be the world wide sole distributor of CONOR Medsystems COSTAR paclitaxel stent. Radically different from conventional drug eluting stents, the CONOR Medsystems stent is the first non-surface-coated drug eluting stent designed to provide advanced drug delivery capabilities. CONOR M...
Company:Biotronik GmbH & Co.

RX HERCULINK® PLUS Biliary Stent System

Description: The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0 mm for the 15mm and 18mm stent lengths....
Company:Guidant Corporation

DYNALINK® 0.018 Biliary Self-Expanding Stent System

Description: The DYNALINK .018 Biliary Self-Expanding Stent System combines low-profile, high radial force, and excellent deliverability in one system. This .018" guide wire compatible stent system provides 6F sheath / 8F guiding catheter compatibility in all diameters (5.0 - 10.0 mm). Now, with longer stents a...
Company:Guidant Corporation

OMNILINK® 0.035 Biliary Stent System

Description: The OMNILINK®.035 Biliary Stent System is a supportive .035" guide wire compatible stent system available in diameters of 5.0 - 10.0 mm in lengths of 18 mm, 28 mm, 38 mm and 58 mm and 4.0 - 7.0 mm diameters available in 12 and 16 mm lengths. The 4.0 mm diameter is also available in 18mm length...
Company:Guidant Corporation

ABSOLUTE™ 0.035 Biliary Self-Expanding Stent System

Description: Unique triaxial catheter design and ergonomic handle for easy and accurate deployment. Six proprietary radiopaque Nitinol markers on the proximal and distal ends of the stent enhance visibility. Corrugated ring design provides flexibility and radial strength, while the nested ring pattern minimizes...
Company:Guidant Corporation

Magic WALLSTENT® Stent System

Description: Wire mesh braided design with a platinum core....
Company:Boston Scientific Corporation

More>>

Stent in Medical Dictionary

Stent

In medicine, a stent is a man-made 'tube' inserted into a natural passage/conduit in the body to prevent, or counteract, a disease-induced, localized flow constriction. The term may also refer to a tube used to temporarily... A coronary stent is a stent placed in a coronary arter...

Mucosa

...ile in all eyes, making it difficult to anastomose with nasal mucosa . ... fibrous adhesions between the lacrimal sac mucosa and the head of the stent may ... ... different mucin genes in the ileal mucosa of patients with Crohn's disease and controls. ... healthy and involved ileal mucosa...

Graft

...r experts who offer minimally invasive ... The stent graft procedure is not for everyone, though. ..... terms which emerged ... Learn more about AAA stent grafts , risks involved, prep guidelines and wha.... Reasons for Getting an Abdominal Aortic Aneurysm stent Graft ... Read about heart bypass surgery...

Biliary stricture

..... ... Procedure and Where Is It Performed? Biliary stenting is usually performed in the xray ... If a biliary stricture becomes evident, a stent may then be placed. ... A biliary stricture is an abnormal narrowing of the common bile duct, the tube ... Recurrent inflammation of the ...

Artery

...ondition in which a fatty material called plaque ... Figure C show a carotid artery that has plaque buildup and reduced blood flow. ... The stent stays in the artery permanently, holds it open, improves blood flow to ... Angioplasty Versus Bypass Surgery for Coronary Artery Disease ... ...

Angioplasty

...or the exam, benefits, risks ... Learn all about angioplasty and three types of procedures available -- balloon angioplasty , atherectomy, and stent placement. Angioplasty and stents are commonly used to treat heart disease today. Learn more about them. ... that can be done during angio...

Angiography

...ough the brain. Definition and uses of angiography or angiogram, performed by interventional radiologists. ... Angiography . Angioplasty & stent placement. Cancer - Bone ... Aortic angiography . Cerebral angiography . Coronary angiography . Extremity arteriography ... angiography . Lym...

Stent in Biological News

Goulbourne earns NSF award to research heart stent sensors

Blacksburg, Va. -- Innovative work on a new type of heart stent sensor is earning Nakhiah Goulbourne, assistant professor of mechanical engineering at Virginia Tech, a National Science Foundation Faculty Early Career Development (CAREER) award of $400,000. The focus of Goulbourne's research is...

Olympus broadens portfolio with new biliary metallic stent

CENTER VALLEY, Pa., June 1, 2009 Olympus America Inc. today expanded its medical portfolio by introducing the X-Suit NIR, a biliary metallic stent designed with exceptional anatomic conformability and superior radial support. The X-Suit NIR's proprietary NIRflex cell design provides a physician s...

12-month ATLANTA trial data show sustained benefit of Catania Stent

WASHINGTON, Oct. 13 -- Clinical investigators at today's "Innovative Devices and Futuristic Therapies" session during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, presented 12-month follow-up data from th...

The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent

ABBOTT PARK, Ill., March 13, 2008 Data published today in The Lancet from ABSORB, the worlds first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-t...

New drug may reduce heart attack damage

...models have found. The drug also reduces incidental cell and tissue death resulting from life-saving interventions such as balloon angioplasty and stent placements, or from the delivery of clot-busting drugs. Significantly, the heart's pumping action is protected by the drug, dramatically improving...

Journal of Vascular and Interventional Radiology: New patient radiation safety guidelines

...tion for cancer); transjugular intrahepatic portosystemic shunt (TIPS) creation for liver disease; and renal and/or visceral artery angioplasty and/or stent placement. "The value of medical imaging is great and the risks of radiation dose are generally negligible compared to the health benefits of havin...

Interventional treatment can be recommended as first-line treatment for 'silent killer'

...asive interventional radiology treatment that uses stent grafts to treat abdominal aortic aneurysms (AAA), ...ns who were considered too sick for major surgery. stent grafts (tubes composed of fabric supported by meta...vocated revising current surveillance of patients' stent grafts by CT scans to check for delayed appearance...

Promising 3-year data: Saving limbs with drug-eluting stents

...logged blood vessel and then places a drug-eluting stent in that artery. The stent acts as scaffolding to hold the narrowed artery op...angioplasty and placement of either a drug-eluting stent (with sirolimus, an immunosuppressant drug) or a b...

UNC scientists teach enzyme to make synthetic heparin in more varieties

...l lining of pigs. The manufactured form of the substance is most often used during and after procedures such as kidney dialysis, heart bypass surgery, stent implantation, indwelling catheters, and knee and hip replacements to prevent clots from blocking or restricting the flow of blood. The annual worldwid...

OSA's ISP launches with research on breathing disorders and congenital heart defects

...can result. Doctors often treat this condition by inserting a small medical stent into the airway to open it up and ease breathing. Critical to this procedur...is measurement accurately helps doctors choose the most appropriately sized stent for each person. The current clinical practice for imaging the airway co...

Stent in Biological Technology

Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system

VANCOUVER, May 27 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX ) has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) A...

FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System

NATICK, Mass., May 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte (R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-g...

SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System

VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX ) has reported positive outcomes from a substudy of patients with left main coronary disease who were treate...

Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System

Product is Japan's first second-generation drug-eluting stent NATICK, Mass., Jan. 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS(R) Liber...

FDA Approves Boston Scientific's Express(R) SD Renal Stent System

NATICK, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that the U.S. Food and Drug Administration (FDA) has approved the Express(R) SD Renal Monorail(R) Premounted Stent System for use as an adjunct to PTRA (percutaneous transluminal renal ang...

CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East

NEWNAN, Ga., Dec. 3 /PRNewswire/ -- CeloNova BioSciences, Inc., announced today that it has expanded the areas in which it is commercializing the CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F -- a stent system that has not had any stent thrombosis in clinical studies. It is CE Mark...

MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008

TEL AVIV, Israel, November 10 /PRNewswire/ -- InspireMD, developers of the novel MGuard(TM) coronary stent system, announced today that MGuard(TM) was successfully implanted in a complex lesion in a live case at the TCT '08. The procedure was performed by Dr. Dariusz Dudek and was broadcast fr...

Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award

Fourth Innovation Award for Abbott in Six Years Recognizes Breakthrough Treatment for the Most Common Form of Heart Disease ABBOTT PARK, Ill., Oct. 28 /PRNewswire/ -- Abbott today announced it has received a 2008 Chicago Innovation Award for its XIENCE V(TM) Everolimus Eluting Coronar...

Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years

Zero Incidence of Late Stent Thrombosis Reported in CUSTOM I, II, and III Trials WASHINGTON and MENLO PARK, Calif., Oct. 13 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT ) today announced positive long-term follow-up data from the CUSTOM I, II and III clin...

Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During 'Live' Case at the Paris Cardiovascular Interventions Course (Francophone) 2008

Research Shows New Class of Stent Effective in Preventing Thrombosis, Restenosis, and Reocclusion PARIS, Oct. 1 /PRNewswire/ -- CeloNova BioSciences, Inc., today announced that Masahiko Ochiai MD, Associate Professor, Division of Cardiology, Yokohama Hospital, Kanagawa, J...

Stent in Biological Definition

Marfan syndrome

...en used to control some of the complications such as aortic aneurysms . If the dilation of the aorta threatens to lead to rupture, a nickel-titanium stent may be inserted. Rupture of the aorta, or aortic dissection , is the most common cause of sudden death among Marfan syndrome sufferers. The skele...

Stent in Biological Dictionary

Ureter

...f the renal pelvis or ureter is cancer that forms in the pelvis or the tube that carries urine from the kidney to the bladder. A ureteral stent is a thin, flexible tube threaded into the ureter to help urine drain from the kidney to the bladder or to an external collection system. Inj...